{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:07:57Z","timestamp":1785326877524,"version":"3.55.0"},"reference-count":35,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2023.13939","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T12:08:31Z","timestamp":1688472511000},"source":"Crossref","is-referenced-by-count":6,"title":["CLPTM1L expression predicts recurrence of patients with intermediate\u2011 and high\u2011risk stage IB\u2011IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy"],"prefix":"10.3892","volume":"26","author":[{"given":"Yuichiro","family":"Awazu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eijiro","family":"Uchikura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenori","family":"Nanno","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Yasui","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 5454\u20118585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"key20230807130240_b1-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20230807130240_b2-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"660","DOI":"10.6004\/jnccn.2020.0027","article-title":"NCCN guidelines insights: Cervical cancer, version 1.2020","volume":"18","author":"Abu-Rustum","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"key20230807130240_b3-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-018-1351-y","article-title":"Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer","volume":"24","author":"Ebina","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"key20230807130240_b4-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ygyno.2018.04.009","article-title":"Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067)","volume":"149","author":"Matoda","year":"2018","journal-title":"Gynecol Oncol"},{"key":"key20230807130240_b5-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"e73837","DOI":"10.1371\/journal.pone.0073837","article-title":"Adjuvant chemotherapy, a valuable alternative option in selected patients with cervical cancer","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"key20230807130240_b6-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1447-0756.2008.00739.x","article-title":"Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy","volume":"34","author":"Hosaka","year":"2008","journal-title":"J Obstet Gynaecol Res"},{"key":"key20230807130240_b7-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12885-022-09309-6","article-title":"Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: A retrospective study","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cancer"},{"key":"key20230807130240_b8-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11684-021-0892-z","article-title":"Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: A randomized, non-inferiority, multicenter trial","volume":"17","author":"Weng","year":"2023","journal-title":"Front Med"},{"key":"key20230807130240_b9-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"823064","DOI":"10.3389\/fonc.2022.823064","article-title":"Cervical cancer recurrence and patient survival after radical hysterectomy followed by either adjuvant chemotherapy or adjuvant radiotherapy with optional concurrent chemotherapy: A systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"key20230807130240_b10-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.3802\/jgo.2021.32.e44","article-title":"The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: A report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee","volume":"32","author":"Ikeda","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"key20230807130240_b11-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1136\/ijgc-2021-002655","article-title":"Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States","volume":"31","author":"Matsuo","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"key20230807130240_b12-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1006\/bbrc.2001.4250","article-title":"A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis","volume":"280","author":"Yamamoto","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"key20230807130240_b13-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4238\/2012.February.16.2","article-title":"Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma","volume":"11","author":"Chen","year":"2012","journal-title":"Genet Mol Res"},{"key":"key20230807130240_b14-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/carcin\/bgr136","article-title":"Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk","volume":"32","author":"Pande","year":"2011","journal-title":"Carcinogenesis"},{"key":"key20230807130240_b15-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"E118","DOI":"10.1002\/mc.21872","article-title":"Common genetic variants in TERT contribute to risk of cervical cancer in a Chinese population","volume":"51","author":"Wang","year":"2012","journal-title":"Mol Carcinog"},{"key":"key20230807130240_b16-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ng.522","article-title":"A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33","volume":"42","author":"Petersen","year":"2010","journal-title":"Nat Genet"},{"key":"key20230807130240_b17-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ng.687","article-title":"A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci","volume":"42","author":"Rothman","year":"2010","journal-title":"Nat Genet"},{"key":"key20230807130240_b18-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/ijc.27417","article-title":"Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population","volume":"131","author":"Zhao","year":"2012","journal-title":"Int J Cancer"},{"key":"key20230807130240_b19-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5603\/ARM.a2020.0161","article-title":"Study of genetic variants in chromosome 5p15.33 region in non-smoker lung cancer patients","volume":"88","author":"Mandour","year":"2020","journal-title":"Adv Respir Med"},{"key":"key20230807130240_b20-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/CMR.0000000000000641","article-title":"Genome-wide study on uveal melanoma patients finds association to DNA repair gene TDP1","volume":"30","author":"Thomsen","year":"2020","journal-title":"Melanoma Res"},{"key":"key20230807130240_b21-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/ijc.32012","article-title":"CLPTM1L\/CRR9 ectodomain interaction with GRP78 at the cell surface signals for survival and chemoresistance upon ER stress in pancreatic adenocarcinoma cells","volume":"144","author":"Clarke","year":"2019","journal-title":"Int J Cancer"},{"key":"key20230807130240_b22-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1002\/ijc.30288","article-title":"Telomere structure and maintenance gene variants and risk of five cancer types","volume":"139","author":"Karami","year":"2016","journal-title":"Int J Cancer"},{"key":"key20230807130240_b23-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41698-021-00152-9","article-title":"Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L\/CRR9-mediated chemotherapeutic drug resistance","volume":"5","author":"Parashar","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"key20230807130240_b24-ol-26-2-13939","first-page":"237","article-title":"bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis","volume":"55","author":"Sinicrope","year":"1995","journal-title":"Cancer Res"},{"key":"key20230807130240_b25-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20230807130240_b26-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3233\/CBM-160583","article-title":"Prognostic significance of CLPTM1L expression and its effects on migration and invasion of human lung cancer cells","volume":"16","author":"Ni","year":"2016","journal-title":"Cancer Biomark"},{"key":"key20230807130240_b27-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3390\/ijms19082161","article-title":"Mining the plasma cell transcriptome for novel cell surface proteins","volume":"19","author":"Trezise","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20230807130240_b28-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1158\/0008-5472.CAN-13-3176","article-title":"CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells","volume":"74","author":"Jia","year":"2014","journal-title":"Cancer Res"},{"key":"key20230807130240_b29-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1111\/jog.15632","article-title":"Impact of different postoperative adjuvant therapies on the survival of early-stage cervical cancer patients with one intermediate-risk factor: A multicenter study of 14 years","volume":"49","author":"Ye","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"key":"key20230807130240_b30-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/gyno.1996.0087","article-title":"Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): A randomized phase III trial","volume":"61","author":"Curtin","year":"1996","journal-title":"Gynecol Oncol"},{"key":"key20230807130240_b31-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/0008-5472.CAN-13-1617","article-title":"CRR9\/CLPTM1L regulates cell survival signaling and is required for Ras transformation and lung tumorigenesis","volume":"74","author":"James","year":"2014","journal-title":"Cancer Res"},{"key":"key20230807130240_b32-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"e36116","DOI":"10.1371\/journal.pone.0036116","article-title":"Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus","volume":"7","author":"James","year":"2012","journal-title":"PLoS One"},{"key":"key20230807130240_b33-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1158\/1535-7163.MCT-15-0717","article-title":"Novel Anti-CRR9\/CLPTM1L antibodies with antitumorigenic activity inhibit cell surface accumulation, PI3K interaction, and survival signaling","volume":"15","author":"Pusk\u00e1s","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"key20230807130240_b34-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00001622-200011000-00006","article-title":"Regulation of Bcl-xL: A little bit of this and a little bit of STAT","volume":"12","author":"Grad","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"key20230807130240_b35-ol-26-2-13939","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3892\/mco.2013.112","article-title":"Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG\/TGCU Intergroup Surveillance","volume":"1","author":"Shimada","year":"2013","journal-title":"Mol Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T10:06:48Z","timestamp":1691402808000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2023.13939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,7,4]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2023.13939","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"article-number":"353"}}